Skip to content

CMS's CRUSH Rule: A PESTLE Analysis of the Medicare Advantage Audit Shock

CMS wants to recover Medicare Advantage overpayments by extrapolating audits to 2018. UnitedHealth and Humana sold off. What that changes in the PESTLE.

The Hubert H. Humphrey Building, headquarters of the U.S. Department of Health and Human Services, in Washington, D.C.
Photo: Carol M. Highsmith, public domain, via Wikimedia Commons
Published:

On Monday, November 16, the Centers for Medicare & Medicaid Services issued a proposed rule it calls CRUSH, for Comprehensive Regulations to Uncover Suspicious Healthcare. The press release sells it as a fraud crackdown that could save taxpayers nearly $90 billion over 10 years.

The market heard something more specific.

On Wednesday, November 18, UnitedHealth fell 10.2% to $349.91. Humana fell 13% to $385.78. That was the second session after the proposal came out, and it brought the two-day drops to about 15.1% and 16.4% from Monday's closes. CVS Health, which owns Aetna, fell 5.2% to $81.35. Cigna declined 3%. UnitedHealth is one of the Dow's largest components, with a 4.32% weighting, and it dragged the index lower.

Here's the thing. The $90 billion is not a broad cleanup of fake wheelchairs and phantom hospice enrollments, even though those are the examples CMS used to sell the rule. In the agency's own impact tables, $90.2 billion is the estimated transfer from Medicare Advantage plans to the federal government if CMS extrapolates audit findings, starting with payment year 2018.

That is a Legal and Political shock to the insurers that run private Medicare. Below, I go factor by factor through what changes, and what it does to my healthcare industry analysis and insurance market SWOT.